Inhibitory effect of lactoferrin-coated zinc nanoparticles on SARS-CoV-2 replication and entry along with improvement of lung fibrosis induced in adult male albino rats

[1]  J. McVernon,et al.  WHO keeps covid-19 a public health emergency of international concern , 2023, BMJ.

[2]  F. Otero-Espinar,et al.  Biomedical Applications of Lactoferrin on the Ocular Surface , 2023, Pharmaceutics.

[3]  F. Moradian,et al.  Evaluation of the effect of nano-encapsulated lactoferrin on the expression of Bak and Bax genes in gastric cancer cell line AGS and study of the molecular docking of lactoferrin with these proteins. , 2023, Gene.

[4]  V. Fogliano,et al.  Hydrolysis improves the inhibition efficacy of bovine lactoferrin against infection by SARS-CoV-2 pseudovirus , 2022, International Dairy Journal.

[5]  Ali I. Al-Gareeb,et al.  Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals , 2022, Inflammopharmacology.

[6]  H. Farhangi,et al.  Corrigendum to “Effects of different elevated temperature and long-term exposure on microstructural evolution and mechanical characteristics of IN617 Ni-based superalloy” [Mater. Sci. Eng. A 841 (2022) 143025] , 2022, Materials Science & Engineering: A.

[7]  Milan Surjit,et al.  Antiviral Activity of Zinc Oxide Nanoparticles and Tetrapods Against the Hepatitis E and Hepatitis C Viruses , 2022, Frontiers in Microbiology.

[8]  Jason P. Gleghorn,et al.  Artificial engineering of the protein corona at bio-nano interfaces for improved cancer-targeted nanotherapy. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[9]  C. del Rio,et al.  COVID-19 in 2022-The Beginning of the End or the End of the Beginning? , 2022, JAMA.

[10]  H. S. Hassan,et al.  Assessment of antimicrobial, cytotoxicity, and antiviral impact of a green zinc oxide/activated carbon nanocomposite , 2022, Scientific reports.

[11]  T. Hopp,et al.  Characterization of proteolytic degradation products of vaginally administered bovine lactoferrin , 2022, PloS one.

[12]  Pranjal Chandra,et al.  Design and Development of Lactoferrin Conjugated Lipid-polymer Nano-bio-hybrid for Cancer Theranostics , 2022, Materials Today Communications.

[13]  H. Farhangi,et al.  Effects of different elevated temperature and long-term exposure on microstructural evolution and mechanical characteristics of IN617 Ni-based superalloy , 2022, Materials Science and Engineering: A.

[14]  S. Vijayakumar,et al.  Preparation and characterization of amine-functionalized mupirocin-loaded zinc oxide nanoparticles: A potent drug delivery agent in targeting human epidermoid carcinoma (A431) cells , 2022, Journal of Drug Delivery Science and Technology.

[15]  Uxía Regueiro,et al.  Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery. , 2022, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  J. Hiscott,et al.  The Coronavirus pandemic – 2022: Viruses, variants & vaccines , 2022, Cytokine & Growth Factor Reviews.

[17]  M. Vinceti,et al.  Zinc and selenium supplementation in COVID-19 prevention and treatment: a systematic review of the experimental studies , 2022, Journal of Trace Elements in Medicine and Biology.

[18]  Gangadhara Angajala,et al.  Review on metal nanoparticles as nanocarriers: current challenges and perspectives in drug delivery systems , 2022, Emergent Materials.

[19]  Meiwan Chen,et al.  The impact of protein corona on the biological behavior of targeting nanomedicines. , 2022, International journal of pharmaceutics.

[20]  R. Aydın,et al.  Green and cost-effective synthesis of zinc oxide thin films by L-ascorbic acid (AA) and their potential for electronics and antibacterial applications , 2021, Ceramics International.

[21]  H. Patel,et al.  The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19 , 2021, Topics in Current Chemistry.

[22]  G. Cichosz,et al.  Antioxidant, antimicrobial and anticarcinogenic activities of bovine milk proteins and their hydrolysates - a review , 2021, International Dairy Journal.

[23]  F. Iacovelli,et al.  Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences , 2021, Frontiers in Pharmacology.

[24]  G. Sotiriou,et al.  Antiviral Activity of Silver, Copper Oxide and Zinc Oxide Nanoparticle Coatings against SARS-CoV-2 , 2021, Nanomaterials.

[25]  Sangdun Choi,et al.  Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication , 2021, Cells.

[26]  S. Sur,et al.  Modeling Substrate Coordination to Zn-Bound Angiotensin Converting Enzyme 2 , 2021, International Journal of Peptide Research and Therapeutics.

[27]  R. Linhardt,et al.  Oral fate and stabilization technologies of lactoferrin: a systematic review , 2021, Critical reviews in food science and nutrition.

[28]  M. Zimecki,et al.  The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm , 2021, International Immunopharmacology.

[29]  M. Karsdal,et al.  Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis , 2021, Respiratory Research.

[30]  Jun Wang,et al.  The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor , 2021, Emerging microbes & infections.

[31]  Agnieszka Czyżowska,et al.  Cytotoxicity of zinc oxide nanoparticles to innate and adaptive human immune cells , 2020, Journal of applied toxicology : JAT.

[32]  R. Taneja,et al.  Diagnosis and Management of Acute Respiratory Distress Syndrome in a Time of COVID-19 , 2020, Diagnostics.

[33]  J. Kos,et al.  The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors , 2020, PLoS pathogens.

[34]  Yidan Wang,et al.  Lactoferrin for the treatment of COVID-19 (Review) , 2020, Experimental and therapeutic medicine.

[35]  D. Francisci,et al.  Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain , 2020, Frontiers in Chemistry.

[36]  R. Mehanna,et al.  Histological and Physiological Studies of the Effect of Bone Marrow-Derived Mesenchymal Stem Cells on Bleomycin Induced Lung Fibrosis in Adult Albino Rats , 2020, Tissue engineering and regenerative medicine.

[37]  R. Squitti,et al.  Zinc and COVID-19: Basis of Current Clinical Trials , 2020, Biological Trace Element Research.

[38]  V. Cauda,et al.  The investigation of the parameters affecting the ZnO nanoparticle cytotoxicity behaviour: a tutorial review. , 2020, Biomaterials science.

[39]  E. El‐Fakharany,et al.  Nanoformulation of lactoferrin potentiates its activity and enhances novel biotechnological applications. , 2020, International journal of biological macromolecules.

[40]  Jia-You Fang,et al.  Lactoferrin, a multi-functional glycoprotein: Active therapeutic, drug nanocarrier & targeting ligand , 2020, Biomaterials.

[41]  A. Madadlou.  Food proteins are a potential resource for mining cathepsin L inhibitory drugs to combat SARS-CoV-2 , 2020, European Journal of Pharmacology.

[42]  P. Libby,et al.  Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients , 2020, Pharmacology & Therapeutics.

[43]  A. Wells,et al.  Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy , 2020, The Lancet Respiratory Medicine.

[44]  Babak ValizadehKaji,et al.  Effects of green synthesized zinc and copper nano-fertilizers on the morphological and biochemical attributes of basil plant , 2020 .

[45]  K. Basavaiah,et al.  Green synthesis of zinc oxide nanostructures and investigation of their photocatalytic and bactericidal applications , 2019, RSC advances.

[46]  Masoumeh Zahmatkeshan,et al.  Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine , 2019, Journal of Biomedical Science.

[47]  Sapna M. Borah,et al.  Lactoferrin adsorption onto silver nanoparticle interface: Implications of corona on protein conformation, nanoparticle cytotoxicity and the formulation adjuvanticity , 2019, Chemical Engineering Journal.

[48]  E. Nozik-Grayck,et al.  Oxidative Toxicology of Bleomycin: Role of the Extracellular Redox Environment. , 2019, Current opinion in toxicology.

[49]  G. Raghu,et al.  Lung transplantation in idiopathic pulmonary fibrosis , 2018, Expert review of respiratory medicine.

[50]  S. Black,et al.  ROS Signaling in the Pathogenesis of Acute Lung Injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) , 2017, Advances in experimental medicine and biology.

[51]  Thavendran Govender,et al.  The role of nanotechnology in the treatment of viral infections , 2017, Therapeutic advances in infectious disease.

[52]  P. Valenti,et al.  Lactoferrin Efficiently Counteracts the Inflammation-Induced Changes of the Iron Homeostasis System in Macrophages , 2017, Front. Immunol..

[53]  V. Puntes,et al.  Size-Dependent Protein-Nanoparticle Interactions in Citrate-Stabilized Gold Nanoparticles: The Emergence of the Protein Corona. , 2017, Bioconjugate chemistry.

[54]  C. Vancheri,et al.  New perspectives on management of idiopathic pulmonary fibrosis , 2016, Therapeutic advances in chronic disease.

[55]  R. Kanwar,et al.  Oral administration of encapsulated bovine lactoferrin protein nanocapsules against intracellular parasite Toxoplasma gondii , 2015, International journal of nanomedicine.

[56]  R. Perlmutter,et al.  Lactoferrin , 2015, Experimental Biology and Medicine.

[57]  Natpasit Chaithanatkun,et al.  Effect of ascorbic acid on structural properties of ZnO nanoparticles prepared by precipitation process , 2015, 10th IEEE International Conference on Nano/Micro Engineered and Molecular Systems.

[58]  Shih-Yin Chen,et al.  Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. , 2014, The Lancet. Respiratory medicine.

[59]  S. Arévalo-Gallegos,et al.  Immunomodulatory effects of lactoferrin , 2014, Acta Pharmacologica Sinica.

[60]  R. Speth,et al.  Concentration‐dependent effects of zinc on angiotensin‐converting enzyme‐2 activity (1067.4) , 2014 .

[61]  E. Redwan,et al.  Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study , 2013, Virology Journal.

[62]  D. Lane,et al.  Mammalian iron homeostasis in health and disease: uptake, storage, transport, and molecular mechanisms of action. , 2013, Antioxidants & redox signaling.

[63]  Z. Yıldırım,et al.  Effect of Resveratrol on Treatment of Bleomycin-Induced Pulmonary Fibrosis in Rats , 2012, Inflammation.

[64]  P. Espitia,et al.  Zinc Oxide Nanoparticles: Synthesis, Antimicrobial Activity and Food Packaging Applications , 2012, Food and Bioprocess Technology.

[65]  T. Ng,et al.  Examination of the Activity of Camel Milk Casein against Hepatitis C Virus (Genotype-4a) and Its Apoptotic Potential in Hepatoma and HeLa Cell Lines , 2011, Hepatitis monthly.

[66]  Albert Duschl,et al.  Time evolution of the nanoparticle protein corona. , 2010, ACS nano.

[67]  G. Raghu,et al.  Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology , 2010, European Respiratory Journal.

[68]  J. Actor,et al.  Lactoferrin as a natural immune modulator. , 2009, Current pharmaceutical design.

[69]  K. Yamauchi,et al.  Inhibitory Effects of Lactoferrin on Growth and Biofilm Formation of Porphyromonas gingivalis and Prevotella intermedia , 2009, Antimicrobial Agents and Chemotherapy.

[70]  S. González-Chávez,et al.  Lactoferrin: structure, function and applications. , 2009, International journal of antimicrobial agents.

[71]  Miguel Calvo Rebollar,et al.  Isolation of lactoferrin from milk of different species: calorimetric and antimicrobial studies. , 2008, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[72]  B. Haroun,et al.  Potential Activity of Camel Milk-Amylase and Lactoferrin against Hepatitis C Virus Infectivity in HepG2 and Lymphocytes , 2008 .

[73]  W. Altemeier,et al.  Hyperoxia in the intensive care unit: why more is not always better , 2007, Current opinion in critical care.

[74]  K. Ando,et al.  Enteric‐formulated lactoferrin was more effectively transported into blood circulation from gastrointestinal tract in adult rats , 2006, Experimental physiology.

[75]  K. Yamauchi,et al.  Lactoferrin inhibits lipid peroxidation in patients with chronic hepatitis C. , 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

[76]  Jian Qin,et al.  The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. , 2006, Nano letters.

[77]  H. Baker,et al.  Molecular structure, binding properties and dynamics of lactoferrin. , 2005, Cellular and molecular life sciences : CMLS.

[78]  D. Meijer,et al.  Antiviral activity of human lactoferrin: inhibition of alphavirus interaction with heparan sulfate. , 2005, Virology.

[79]  T. Standiford,et al.  Sublethal Hyperoxia Impairs Pulmonary Innate Immunity1 , 2003, The Journal of Immunology.

[80]  H. Sekihara,et al.  Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[81]  J. Lasky,et al.  Interstitial fibrosis and growth factors. , 2000, Environmental health perspectives.

[82]  P. Valenti,et al.  Metal complexes of lactoferrin and their effect on the intracellular multiplication of Legionella pneumophila , 2000, Biometals.

[83]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[84]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[85]  S. Aldred.  Antioxidant , 2020, Definitions.

[86]  K. Yamauchi,et al.  Twenty-five years of research on bovine lactoferrin applications. , 2009, Biochimie.

[87]  B. Lönnerdal,et al.  Characterization of mammalian receptors for lactoferrin. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.